Twitter Beğeni Hilesi

#clinicaltrials #INSIGHT

Don’t miss these #GISTeducation webinars! Register today for 'Treatment for GIST in the Liver', bit.ly/LocoregionalTh…, and 'IDRX-42 Trial Design', bit.ly/IDRX42Webinar #ThrivingTogether #ClinicalTrials

#SDHdeficientGIST affects a small portion of GIST patients but these patients are largely children & young adults. Check your #SDH101 knowledge & learn more about SDH-def GIST from Dr. Andrew Blakely: bit.ly/SDH101-LifeFest #childhoodcancerawarenessmonth #gisteducation

In one hour Dr. Kim of Mount Sinai Medical Center will be presenting “Locoregional Therapies for Treatment of GIST in the Liver”. Register now: bit.ly/LocoregionalTh… #GISTeducation #ThrivingTogether

September is #DesmoidTumorAwarenessMonth. Studies suggest that desmoid & GIST may be related. Learn more in our webinar featuring Drs. Bialick and @jtrentmdphd of Sylvester Comprehensive Cancer Center bit.ly/GISTandDesmoid #GIST #ThrivingTogether #DesmoidAwareness

Ripretinib, an approved for adv. GIST for 4L treatment, is being investigated as a second-line option compared to sunitinib for certain, specific GIST mutation types. Learn about eligibility: bit.ly/INSIGHT-Study-… #clinicaltrialswednesday #ThrivingTogether #GIST Deciphera Pharma

A lot of new breakthroughs in understanding and treatment of Desmoid tumors Sylvester Comprehensive Cancer Center Ty Subhawong Philippos Apolinario Costa, MD Gina Z. D'Amato, MD. Elizabeth Montgomery, MD

There's still time to register for these in-person GIST Days of Learning in Ohio & Calgary! GDOL Ohio 9/14, GDOL Calgary 9/28. bit.ly/GDOLohio bit.ly/GDOL-Calgary #GISTeducation #ThrivingTogether #GISTDayOfLearning

Dr. Edward Kim presented various therapies for treating GIST when it metastasizes to the liver. Recording is now posted: bit.ly/LocoregionalTh… #GISTeducation #ThrivingTogether #liver Mount Sinai Health System

Becky has been battling SDH-deficient GIST for over two decades & shares her story. #ChildhoodCancerAwarenessMonth #SDHdeficientGIST #ThrivingTogether

Olvermatinib in pts with SDH-deficient #GIST 🔸mPFS 22months 🔸mPFS from historical data for sunitinib or regorafenib 5-6m #sarcoma #ESMO24 #ESMOAmbassadors ESMO - Eur. Oncology

First data presented of our study Axitinib plus avelumab in patients with unresectable/metastatic gastrointestinal stromal tumor (GIST) after failure of standard therapy: Single-arm phase II study (AXAGIST) thank you katarzyna kozak Narodowy Instytut Onkologii, Warszawa SPAGN

We’re excited to participate in #ESMO2024! Our poster, Real-world efficacy of imatinib in advanced GIST: The LRG Registry, features contributions from Sara Rothchild, Denisse Evans, Jerry Call, and in collaboration with Dr. Gim Gahyun and Dr. Adrianne Victor from URMC. #GIST

The final speaker of #sarcoma #ed session is #GIST #guru 💊 Sebastian Bauer taking us through the earlier and contemporary clinical trials of #primary GISTs and strategies to deal with #diseaseresistance. Lessons learned from failed early #nilotinib trial before attempting to

Thank you Herbert Loong, MBBS, FASCO . Very proud of our collaborative work on this data project and the opportunity to share it with the #ESMO2024 community. The Life Raft Group

📉LENVAGIST R-P2 trial in met #GIST presented by Jean-Yves Blay -Heavily pretreated population (>3 lines 50%) -mPFS 2.8mo vs 1 mo placebo -1 partial response (5%) ✍️MKIs with anti-KIT activity have (almost) always some degree of activity #ESMO24 #ESMOAmbassadors

On October 7th at 1PM ET, Dr. Suzanne George of @danafarber will discuss the IDRX StrateGIST 1 Study for the GIST patient community. Register now and submit your questions ahead of time: bit.ly/IDRX42Webinar

Our final in-person U.S. GIST Day of Learning for 2024 was last Saturday at Ohio State University w/GIST experts Drs. Tinoco, Iwenofu, Liebner & Grignol presenting. Check out upcoming educational events at: bit.ly/LRGEvents2024 Gabriel Tinoco Valerie Grignol The James

GIST & desmoid tumors impact quality of life in different ways. Speak to a specialist about the best treatment options for the best outcomes possible. #DesmoidTumorAwarenessMonth Link to webinar recording bit.ly/GISTanddesmoid

Starting a new treatment course can be daunting. Be sure to review all your options, including clinical trials, before committing. #ClinicalTrialWednesday